FGF2 and neoplasm: They further found that gold nanoparticles could bind to the heparin-binding domain of VEGF and basic fibroblast growth factor (bFGF) in a size- and surface electrical-dependent manner, and competitively inhibit the binding of VEGF to the receptor VEGFR-2 to achieve the effect of inhibiting angiogenesis and tumor growth.